The fusion lytic peptide Phor 21 conjugated with the FSHβ chain 33–53 fragment (Phor21-FSHβ33-53 C/S) specifically targeted and destroyed cancer cells expressing FSHR. The gene discussed is FSHR; the disease is cancer.